Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The investigators designed a prospective randomized study to compare the conventionally used
sedative drug propofol with a latest alternative dexmedetomidine (DEX), in patients with
end-stage renal disease undergoing arteriovenous fistula (AVF) surgery.